Central mechanisms of nicotine reinforcement and dependence
尼古丁强化和依赖的中心机制
基本信息
- 批准号:7467212
- 负责人:
- 金额:$ 37.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-05 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgonistAmygdaloid structureAnimal ModelAnimalsAnxietyBiochemicalBiologicalBrainCause of DeathCorticotropin-Releasing HormoneDependenceDevelopmentDrug AddictionEnvironmentEtiologyFutureIndividual DifferencesIntakeIntravenousLeadMediatingMicroinjectionsModelingMotivationNeurobiologyNicotineNicotine DependenceNicotine WithdrawalPharmaceutical PreparationsPharmacologyProceduresPsychological reinforcementPublic HealthRattusRewardsSelf AdministrationSiteSmokeStressSystemTestingTobacco smokingTobacco useUnited Statesbasal forebrainbasedeprivationheuristicsinnovationinsightneurobiological mechanismneurochemistryneuropeptide Yresponsetherapy developmenttranslational study
项目摘要
DESCRIPTION (provided by applicant): Tobacco use continues to be a major public health problem in the United States with approximately one-third of users becoming dependent and tobacco smoking is the leading avoidable cause of death in the United States. The present proposal focuses on animal studies to investigate neurobiological mechanisms that mediate nicotine addiction. An animal model of increased intravenous self-administration of nicotine to the point of dependence has been developed and will be further refined, validated and compared to acute reinforcement models. Preliminary results show that a CRF-1 antagonist can block both the anxiety-like responses associated with acute nicotine withdrawal and the increase in nicotine responding produced by nicotine deprivation in an extended access model. The overall hypothesis of the present proposal is that enhanced nicotine seeking in extended access (nicotine-dependent) animals is in part produced by an overactivity of extrahypothalamic corticotropin-releasing factor (CRF) stress systems and related stress modulatory agents in specific regions of the basal forebrain (extended amygdala). To test this hypothesis, three specific aims are proposed: 1). To validate an extended dependence model of nicotine self-administration in rats. 2). To explore the neuropharmacological mechanisms within specific neurochemical systems in the anxiety-like state of nicotine withdrawal. 3). To explore the neuropharmacological mechanisms within specific sites within the extended amygdala on nicotine self-administration in dependent rats. Animal models of intravenous self- administration, anxiety-like responses, and brain stimulation reward combined with biochemical studies, and systemic and intracerebral microinjections of specific neuropharmacological agents will be employed. PUBLIC HEALTH RELEVANCE The proposed neurobiological studies will provide key information not only for the etiology of a major component of the motivation to continue to smoke once dependent, help identify those individual differences that may lead to vulnerability to dependence, and provide key targets for future medications development for the treatment of nicotine dependence.
描述(由申请人提供):烟草使用仍然是美国的一个主要公共卫生问题,大约三分之一的使用者变得依赖烟草,吸烟是美国主要的可避免的死亡原因。目前的提案侧重于动物研究,以调查介导尼古丁成瘾的神经生物学机制。已经开发出一种增加静脉自我注射尼古丁至依赖点的动物模型,并将进一步完善、验证并与急性强化模型进行比较。初步结果表明,CRF-1 拮抗剂可以阻断与急性尼古丁戒断相关的焦虑样反应,以及在长期接触模型中尼古丁剥夺所产生的尼古丁反应增加。本提案的总体假设是,长期接触(尼古丁依赖)动物对尼古丁的寻求增强部分是由下丘脑外促肾上腺皮质激素释放因子(CRF)应激系统和基底前脑(扩展杏仁核)特定区域的相关应激调节剂的过度活跃引起的。为了检验这一假设,提出了三个具体目标:1)。验证大鼠自我给药尼古丁的扩展依赖模型。 2)。探讨尼古丁戒断焦虑样状态下特定神经化学系统内的神经药理学机制。 3)。探讨扩展杏仁核内特定位点对依赖性大鼠尼古丁自我给药的神经药理学机制。将采用静脉自我给药、焦虑样反应和脑刺激奖励与生化研究相结合的动物模型,以及特定神经药理学药物的全身和脑内显微注射。公共健康相关性拟议的神经生物学研究不仅将提供关键信息,不仅为一旦成瘾后继续吸烟的动机的主要组成部分的病因学提供关键信息,帮助识别可能导致依赖的个体差异,并为未来治疗尼古丁依赖的药物开发提供关键目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George F. Koob其他文献
Increases in intracranial self-stimulation in the posterior hypothalamus following unilateral lesions in the locus coeruleus
- DOI:
10.1016/0006-8993(76)90478-9 - 发表时间:
1976-01-23 - 期刊:
- 影响因子:
- 作者:
George F. Koob;G. Jean Balcom;James L. Meyerhoff - 通讯作者:
James L. Meyerhoff
Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats
促肾上腺皮质激素释放因子拮抗剂可阻止大鼠应激引起的打斗
- DOI:
10.1016/0167-0115(87)90048-6 - 发表时间:
1987 - 期刊:
- 影响因子:0
- 作者:
A. Tazi;R. Dantzer;M. Moal;J. Rivier;W. Vale;George F. Koob - 通讯作者:
George F. Koob
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
酒精使用障碍与睡眠障碍:前馈性稳态失衡框架
- DOI:
10.1038/s41386-019-0446-0 - 发表时间:
2019-06-24 - 期刊:
- 影响因子:7.100
- 作者:
George F. Koob;Ian M. Colrain - 通讯作者:
Ian M. Colrain
Role of Corticotropin-Releasing Factor in Drug Addiction
- DOI:
10.2165/11587790-000000000-00000 - 发表时间:
2011-04-01 - 期刊:
- 影响因子:7.400
- 作者:
Marian L. Logrip;George F. Koob;Eric P. Zorrilla - 通讯作者:
Eric P. Zorrilla
Stress, performance, and arousal: focus on CRF.
压力、表现和唤醒:关注 CRF。
- DOI:
10.1037/e475522004-001 - 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
George F. Koob;Belinda J. Cole;Neal R. Swerdlow;M. LeMoal;K. Britton - 通讯作者:
K. Britton
George F. Koob的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George F. Koob', 18)}}的其他基金
The Role of Brain Stress Systems in the Prefrontal Cortex in Compulsive Drinking
前额皮质大脑压力系统在强迫性饮酒中的作用
- 批准号:
8308410 - 财政年份:2011
- 资助金额:
$ 37.9万 - 项目类别:
The Role of Brain Stress Systems in the Prefrontal Cortex in Compulsive Drinking
前额皮质大脑压力系统在强迫性饮酒中的作用
- 批准号:
8161020 - 财政年份:2011
- 资助金额:
$ 37.9万 - 项目类别:
Effects of Deep Brain Stimulation on Compulsive Drug Intake
深部脑刺激对强迫性药物摄入的影响
- 批准号:
8114767 - 财政年份:2011
- 资助金额:
$ 37.9万 - 项目类别:
Effects of Deep Brain Stimulation on Compulsive Drug Intake
深部脑刺激对强迫性药物摄入的影响
- 批准号:
8249804 - 财政年份:2011
- 资助金额:
$ 37.9万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 37.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)